Shares of Shilpa Medicare were trading 3% higher on 3 November after the company announced acquiring United States-based Pilnova Pharma, which has now become the...
Shilpa Medicare announced on 4 September that it had received approval from the UK healthcare products regulator to market a Meniere’s syndrome drug. The company...
Shares of Shilpa Medicare fell 5% in early trading on May 26, as the drugmaker reported disappointing earnings for Q3FY22-23. The drugmaker posted a net...
The Shilpa Medicare share price mounted 9% in the opening trade on Tuesday soon after the company acknowledged the final approval for its Apremilast tablets...
As part of the semi-annual review of the National Stock Exchange’s broader market index, Adani Wilmar, Varun Beverages, Canara Bank, Page Industries, and ABB India...
Shilpa Medicare has received establishment inspection report (EIR), from United States Food and Drug Administration (USFDA). The company has received of EIR for both API manufacturing...
Shilpa Medicare has received Form no 483 observations, related to SEZ formulation facilities situated at Jadcherla, Telangana, from the United States Food & Drug Administration (USFDA)....
The US health regulator has issued an Establishment Inspection Report (EIR) to Shilpa Medicare for its manufacturing facilities located at Raichur in Karnataka. Shilpa Medicare...